Previous studies have demonstrated that chemotherapy-exposed tumor cells secrete EVs with distinct molecular signatures, including enhanced levels of TGF-β, heat shock proteins, and ROS-associated metabolites, which can exert deleterious effects on distant nontumor cells [35,37]. This evidence concerns the gene TGFB1 and neoplasm.